SCHEMBL4740343

SCHEMBL4740343

NS(=O)(=O)Nc1cnccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.44
▸ EDNRA P25101 1/20 0.42
▸ KMT2A Q03164 3/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ HPGD P15428 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ TSHR P16473 2/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ MC4R P32245 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ MC3R P41968 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3432475 0.79 EDNRA (0.46) ACHEEDNRAKMT2AALDH1A1KDM4E
SCHEMBL30562266 0.79 EDNRA (0.46) ACHEEDNRAKMT2AALDH1A1KDM4E
SCHEMBL23562355 0.76 EDNRA (0.43) ACHEEDNRAKMT2AALDH1A1KDM4E
SCHEMBL28468524 0.76 PTGS1 (0.45) —
SCHEMBL20333510 0.75 ACHE (0.48) ACHEEDNRAKMT2AALDH1A1KDM4E
SCHEMBL152522 0.73 SMN1; SMN2 (0.65) EDNRAKMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL30339084 0.73 PTGS1 (0.46) ACHEEDNRA
SCHEMBL30338582 0.73 PTGS1 (0.46) ACHEEDNRA
SCHEMBL28409808 0.72 SMN1; SMN2 (0.63) EDNRAKMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL22355191 0.72 ACHE (0.46) ACHEEDNRAKMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660461-B1 NOVEL CONDENSED N-PYRAZINYL-SULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2008-10-22 — — EP disclosed
EP-1660461-A1 NOVEL CONDENSED N-PYRAZINYL-SULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES AstraZeneca AB (SE) 2006-05-31 — — EP disclosed
WO-2005021513-A1 NOVEL CONDENSED N-PYRAZINYL-SULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2005-03-10 — — WO disclosed
Send feedback